全文获取类型
收费全文 | 1809篇 |
免费 | 104篇 |
国内免费 | 5篇 |
专业分类
耳鼻咽喉 | 25篇 |
儿科学 | 60篇 |
妇产科学 | 88篇 |
基础医学 | 193篇 |
口腔科学 | 51篇 |
临床医学 | 136篇 |
内科学 | 427篇 |
皮肤病学 | 11篇 |
神经病学 | 96篇 |
特种医学 | 64篇 |
外科学 | 343篇 |
综合类 | 26篇 |
预防医学 | 84篇 |
眼科学 | 14篇 |
药学 | 73篇 |
中国医学 | 6篇 |
肿瘤学 | 221篇 |
出版年
2023年 | 19篇 |
2022年 | 10篇 |
2021年 | 49篇 |
2020年 | 20篇 |
2019年 | 39篇 |
2018年 | 56篇 |
2017年 | 51篇 |
2016年 | 32篇 |
2015年 | 35篇 |
2014年 | 59篇 |
2013年 | 78篇 |
2012年 | 135篇 |
2011年 | 132篇 |
2010年 | 68篇 |
2009年 | 62篇 |
2008年 | 111篇 |
2007年 | 145篇 |
2006年 | 103篇 |
2005年 | 98篇 |
2004年 | 109篇 |
2003年 | 126篇 |
2002年 | 102篇 |
2001年 | 28篇 |
2000年 | 20篇 |
1999年 | 17篇 |
1998年 | 17篇 |
1997年 | 22篇 |
1996年 | 18篇 |
1995年 | 14篇 |
1994年 | 8篇 |
1993年 | 5篇 |
1992年 | 8篇 |
1991年 | 6篇 |
1990年 | 8篇 |
1989年 | 11篇 |
1988年 | 4篇 |
1987年 | 5篇 |
1986年 | 4篇 |
1985年 | 3篇 |
1984年 | 7篇 |
1982年 | 5篇 |
1981年 | 7篇 |
1979年 | 6篇 |
1978年 | 6篇 |
1977年 | 3篇 |
1976年 | 3篇 |
1975年 | 4篇 |
1971年 | 3篇 |
1966年 | 3篇 |
1964年 | 3篇 |
排序方式: 共有1918条查询结果,搜索用时 15 毫秒
991.
Emile Daraï Marie Carbonnel Gil Dubernard Vincent Lavoué Charles Coutant Marc Bazot Marcos Ballester 《European journal of obstetrics, gynecology, and reproductive biology》2010
Objective
The aims of this prospective study were to evaluate fertility, pregnancy outcomes and their determinant factors after laparoscopic segmental colorectal resection for endometriosis.Study design
We studied 83 women who underwent colorectal resection for endometriosis. Thirty-nine women (47%) had an associated infertility and 51 (61.4%) wished to conceive after surgery. Surgical route was exclusive laparoscopy in 77 cases (92.7%) and laparoconversion in 6 (7.3%).Results
Twenty-nine pregnancies were obtained in 24 patients (43.6%) including 20 spontaneous (69%) and 9 by IVF (31%). The median time to conceive spontaneously was 6 months and 20 months by IVF. Among the 39 infertile women, 18 (46%) conceived during the study period. A relation was found between pregnancy rate and patient age (p = 0.02). Reduction in pregnancy rate was correlated to the presence of adenomyosis (p = 0.04) and high ASRM total score (p < 0.001) as well as exclusive laparoscopy compared to conversion to laparotomy for colorectal resection (p = 0.01).Conclusion
Adenomyosis and conversion to laparotomy as well as patient age, ASRM score appeared determinant factors of fertility outcome. 相似文献992.
Stephanie G.C. Kroeze Joost S. Vermaat Aram van Brussel Harm H.E. van Melick Emile E. Voest Trudy G.N. Jonges Paul J. van Diest John Hinrichs J.L.H. Ruud Bosch Judith J.M. Jans 《European journal of cancer (Oxford, England : 1990)》2010,46(18):3375-3382
AimThe hypoxia inducible factor (HIF) pathway plays an important role in sporadic clear cell renal cell carcinoma (ccRCC) by stimulating processes of angiogenesis, cell proliferation, cell survival and metastases formation. Herein, we evaluate the significance of upstream proteins directly regulating the HIF pathway; the prolyl hydroxylases domain proteins (PHD)1, 2 and 3 and factor-inhibiting HIF (FIH), as prognostic markers for ccRCC.MethodsImmunohistochemical marker expression was examined on a tissue microarray containing tumour tissue derived from 100 patients who underwent nephrectomy for ccRCC. Expression levels of HIF, FIH and PHD1, 2 and 3 were correlated with overall survival (OS) and clinicopathological prognostic factors.ResultsHIF-1α was positively correlated with HIF-2α (p < 0.0001), PHD1 (p = 0.024), PHD2 (p < 0.0001), PHD3 (p = 0.004), FIH (p < 0.0001) and VHL (p = 0.031). HIF-2α levels were significantly associated with FIH (p < 0.0001) and PHD2 (p = 0.0155). Mutations in the VHL gene, expression variations of HIF-1α, HIF-2α and PHD1, 2, 3 did not show a correlation to OS or clinicopathological prognostic factors. Tumour stage, grade, diameter, metastastic disease and intensity of nuclear FIH were significantly correlated to OS in univariable analysis (p = 0.023). Low nuclear FIH levels remained a strong independent prognostic factor in multivariable analysis (p = 0.009).ConclusionThese results show that low nuclear expression of FIH is a strong independent prognostic factor for a poor overall survival in ccRCC. 相似文献
993.
Large numbers of inhibitors for polo-like kinases and aurora kinases are currently being evaluated as anticancer drugs. Interest in these drugs is fuelled by the idea that these kinases have unique functions in mitosis. Within the polo-like kinase family, the emphasis for targeted therapies has been on polo-like kinase 1 (PLK1), and in the aurora kinase family drugs have been developed to specifically target aurora kinase A (AURKA; also known as STK6) and/or aurora kinase B (AURKB; also known as STK12). Information on the selectivity of these compounds in vivo is limited, but it is likely that off-target effects within the same kinase families will affect efficacy and toxicity profiles. In addition, it is becoming clear that interplay between polo-like kinases and aurora kinases is much more extensive than initially anticipated, and that both kinase families are important factors in the response to classical chemotherapeutics that damage the genome or the mitotic spindle. In this Review we discuss the implications of these novel insights on the clinical applicability of polo-like kinase and aurora kinase inhibitors. 相似文献
994.
Jeanine M Roodhart Marlies H Langenberg Joost S Vermaat Martijn P Lolkema Arnold Baars Rachel H Giles Els O Witteveen Emile E Voest 《Neoplasia (New York, N.Y.)》2010,12(1):87-94
We and others have previously demonstrated that the acute release of progenitor cells in response to chemotherapy actually reduces the efficacy of the chemotherapy. Here, we take these data further and investigate the clinical relevance of circulating endothelial (progenitor) cells (CE(P)Cs) and modulatory cytokines in patients after chemotherapy with relation to progression-free and overall survival (PFS/OS). Patients treated with various chemotherapeutics were included. Blood sampling was performed at baseline, 4 hours, and 7 and 21 days after chemotherapy. The mononuclear cell fraction was analyzed for CE(P)C by FACS analysis. Plasma was analyzed for cytokines by ELISA or Luminex technique. CE(P)Cs were correlated with response and PFS/OS using Cox proportional hazard regression analysis. We measured CE(P)Cs and cytokines in 71 patients. Only patients treated with paclitaxel showed an immediate increase in endothelial progenitor cell 4 hours after start of treatment. These immediate changes did not correlate with response or survival. After 7 and 21 days of chemotherapy, a large and consistent increase in CE(P)C was found (P < .01), independent of the type of chemotherapy. Changes in CE(P)C levels at day 7 correlated with an increase in tumor volume after three cycles of chemotherapy and predicted PFS/OS, regardless of the tumor type or chemotherapy. These findings indicate that the late release of CE(P)C is a common phenomenon after chemotherapeutic treatment. The correlation with a clinical response and survival provides further support for the biologic relevance of these cells in patients'' prognosis and stresses their possible use as a therapeutic target. 相似文献
995.
Geraldine Perkins Astrid Lièvre Carole Ramacci Tchao Méatchi Aurélien de Reynies Jean‐François Emile Valérie Boige Gorana Tomasic Jean‐Baptiste Bachet Fréderic Bibeau Olivier Bouché Frédérique Penault‐Llorca Pierre Laurent‐Puig 《International journal of cancer. Journal international du cancer》2010,127(6):1321-1331
KRAS mutations are a strong predictive marker of resistance to anti‐epidermal growth factor receptor (EGFR) antibodies in advanced colorectal cancer (CRC) but only a subset of wild‐type (WT) KRAS patients are responders, suggesting the existence of additional markers of resistance to this treatment. The activation of EGFR downstream signaling pathways may be one of these ones. In a series of 42 patients with advanced CRC treated with cetuximab/panitumumab, for whom KRAS status was previously determined, we retrospectively analyzed the intratumor expression of EGFR downstream signaling phosphoproteins of the RAS/MAPK and PI3K/AKT pathways (pERK1/2, pMEK1, pAKT, pP70S6K and pGSK3β) using Bio‐Plex® phosphoprotein array. Association with tumor response, progression‐free survival (PFS) and overall survival (OS) was assessed. The expression of all the phosphoproteins was higher in KRAS mutated tumors than in WT tumors. The expression of pP70S6K was lower in responders than in nonresponder patients. In univariate analysis, patients with high pMEK1 or pP70S6K expression had a shorter PFS than those with low expression. Patients with high pP70S6K expression also had a shorter OS. In multivariate analysis, PFS was shorter for patients with high pMEK1 or pP70S6K expression, independently of KRAS status, as OS for patients with high pP70S6K expression. Therefore, WT KRAS patients with high pP70S6K expression had a shorter survival than those with low expression. Our results suggest the importance of EGFR downstream signaling phosphoproteins expression in addition to KRAS status to define the subgroup of patients who will not benefit from anti‐EGFR therapy. 相似文献
996.
Grete?AndersenEmail authorView authors OrcID profile Karen?Heje Astrid?Emile?Buch John?Vissing 《Journal of neurology》2017,264(6):1099-1106
Increasing evidence suggests that high-intensity training (HIT) is a time-efficient exercise strategy to improve fitness. HIT has never been explored in neuromuscular diseases, likely because it may seem counterintuitive. A single session of high-intensity exercise has been studied without signs of muscle damage in facioscapulohumeral muscular dystrophy type 1 (FSHD1). We aimed to determine whether HIT is safe and effective in FSHD1 in a randomized, controlled parallel study. Untrained adults with genetically verified FSHD1 (n = 13) able to perform cycle-ergometer exercise were randomized to 8 weeks of supervised HIT (n = 6) (3 × 10-min cycle-ergometer-HIT/week) or 8 weeks of usual care (n = 7). Following this, all participants performed 8 weeks of unsupervised HIT (3 × 10-min cycle-ergometer-HIT/week). Primary outcome was fitness, maximal oxygen uptake/min/kg body weight. Furthermore, workload, 6-min walk distance, 5-time sit-to-stand time, muscle strength, and daily activity levels were measured. Pain, fatigue, and plasma-CK were monitored. Twelve patients completed the randomized part of the study. Plasma-CK levels and pain scores were unaffected by HIT. Supervised HIT improved fitness (3.3 ml O2/min/kg, CI 1.2–5.5, P < 0.01, n = 6, NNT = 1.4). Unsupervised HIT also improved fitness (2.0 ml O2/min/kg, CI 0.1–3.9, P = 0.04, n = 4). There was no training effect on other outcomes. Patients preferred HIT over strength and moderate-intensity aerobic training. It may seem counterintuitive to perform HIT in muscular dystrophies, but this RCT shows that regular HIT is safe, efficacious, and well liked by moderately affected patients with FSHD1, which suggests that HIT is a feasible method for rehabilitating patients with FSHD1. 相似文献
997.
Alexandre de Nonneville Anthony Gonçalves Christophe Zemmour Jean M. Classe Monique Cohen Eric Lambaudie Fabien Reyal Christophe Scherer Xavier Muracciole Pierre E. Colombo Sylvia Giard Roman Rouzier Richard Villet Nicolas Chopin Emile Darai Jean R. Garbay Pierre Gimbergues Laura Sabiani Charles Coutant Renaud Sabatier François Bertucci Jean M. Boher Gilles Houvenaeghel 《Breast cancer research and treatment》2017,162(2):307-316
Purpose
Benefit of adjuvant trastuzumab-based chemotherapy for node-positive and/or >1 cm human epidermal growth factor receptor 2-positive (HER2+) breast carcinomas has been clearly demonstrated in randomized clinical trials. Yet, evidence that adjuvant chemotherapy with or without trastuzumab is effective in pT1abN0 HER2+ tumors is still limited. The primary objective of this study was to investigate the impact of adjuvant chemotherapy ± trastuzumab on outcome in this subpopulation.Patients and methods
A total of 356 cases of pT1abN0M0 HER2 + breast cancers were retrospectively identified from a large cohort of 22,334 patients, including 1248 HER2+ patients who underwent primary surgery at 17 French centers, between December 1994 and January 2014. The primary end point was disease-free survival (DFS). A multivariate Cox model was built, including adjuvant chemotherapy, tumor size, hormone receptor status, and Scarff Bloom Richardson (SBR) grade.Results
A total of 138 cases (39%) were treated with trastuzumab-based chemotherapy, 29 (8%) with chemotherapy alone, and 189 (53%) received neither trastuzumab nor chemotherapy. Adjuvant chemotherapy ± trastuzumab was associated with a significant DFS benefit (3-year 99 vs. 90%, and 5-year 96 vs. 84%, Hazard ratio, HR 0.26 [0.10–0.67]; p = 0.003, logrank test) which was maintained in multivariate analysis (HR 0.19 [0.07–0.52]; p = 0.001). Metastasis-free survival was also increased (HR 0.25 [0.07–0.86]; p = 0.018, logrank test) at 3-year (99 vs. 95%) and 5-year (98 vs. 89%) censoring. Exploratory subgroup analysis found DFS benefit to be significant in hormone receptor-negative, hormone receptor-positive, and pT1b tumors, but not in pT1a tumors.Conclusions
Adjuvant chemotherapy ± trastuzumab is associated with a significantly reduced risk of recurrence in subcentimeter node-negative HER2+ breast cancers. Most of the benefit may be driven by pT1b tumors.998.
Emile Mehanna MD J. Dawn Abbott MD 《Catheterization and cardiovascular interventions》2017,90(7):1115-1116
- Intravascular imaging plays a key role in the identification of mechanisms of acute coronary syndromes
- Post processing IVUS algorithms (IMAP‐IVUS and VH‐IVUS) for tissue characterization have not been widely adopted due to current limitations
- Future development will allow easier, faster, and more accurate identification of vulnerable plaques, ultimately allowing prognostication of various interventions.
999.
A Phase I Dose‐Escalation Study of the Safety and Pharmacokinetics of Pictilisib in Combination with Erlotinib in Patients with Advanced Solid Tumors 下载免费PDF全文
1000.
In continuation to our studies on radioresistance in meningioma, here we show that radiation treatment (7 Gy) induces G2/M cell cycle arrest in meningioma cells. Phosphorylation of Chk2, Cdc25c and Cdc2 were found to be key events since interference with Chk2 activation and cyclin B1/Cdc2 interaction led to permanent arrest followed by apoptosis. Irradiated cells showed recovery and formed aggressive intracranial tumors with rapid spread and morbidity. Nevertheless, knock down of uPAR with or without radiation induced permanent arrest in G2/M phase and subsequent apoptosis in vitro and in vivo. In conclusion, our data suggest that combination treatment with radiation and uPAR knock down or other inhibitors resulting in non-reversible G2/M arrest may be beneficial in the management of meningiomas. 相似文献